Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 6121 AL 6135

Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: a randomized double-blind pilot study

Barak Y, Plopski I, Tadger S, Paleacu D.

Int Psychogeriatr. 2011 Nov;23(9):1515-9. doi: 10.1017/S1041610211000743. Epub 2011 Apr 15.

Persons with mild or moderate Alzheimer's disease use a basic orientation technology to travel to different rooms within a day center

Lancioni GE, Perilli V, Singh NN, O'Reilly MF, Sigafoos J, Bosco A, De Caro MF, Cassano G, Pinto K, Minervini M.

Res Dev Disabil. 2011 Sep-Oct;32(5):1895-901. doi: 10.1016/j.ridd.2011.03.020. Epub 2011 Apr 17.

A phase II trial of huperzine A in mild to moderate Alzheimer disease

Rafii MS, Walsh S, Little JT, Behan K, Reynolds B, Ward C, Jin S, Thomas R, Aisen PS; Alzheimer's Disease Cooperative Study.

Neurology. 2011 Apr 19;76(16):1389-94. doi: 10.1212/WNL.0b013e318216eb7b.

Controlled study on the cognitive and psychological effect of coloring and drawing in mild Alzheimer's disease patients

Hattori H, Hattori C, Hokao C, Mizushima K, Mase T.

Geriatr Gerontol Int. 2011 Oct;11(4):431-7. doi: 10.1111/j.1447-0594.2011.00698.x. Epub 2011 Apr 26.

Alzheimer's disease management guideline: update 2008

Segal-Gidan F, Cherry D, Jones R, Williams B, Hewett L, Chodosh J; California Workgroup on Guidelines for Alzheimer's Disease Management.

Alzheimers Dement. 2011 May;7(3):e51-9. doi: 10.1016/j.jalz.2010.07.005. Epub 2011 May 5.

Apolipoprotein E genotype-specific short-term cognitive benefits of treatment with the antihypertensive nilvadipine in Alzheimer's patients--an open-label trial

Kennelly S, Abdullah L, Kenny RA, Mathura V, Luis CA, Mouzon B, Crawford F, Mullan M, Lawlor B.

Int J Geriatr Psychiatry. 2012 Apr;27(4):415-22. doi: 10.1002/gps.2735. Epub 2011 May 10.

Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD

Vigen CL, Mack WJ, Keefe RS, Sano M, Sultzer DL, Stroup TS, Dagerman KS, Hsiao JK, Lebowitz BD, Lyketsos CG, Tariot PN, Zheng L, Schneider LS.

Am J Psychiatry. 2011 Aug;168(8):831-9. doi: 10.1176/appi.ajp.2011.08121844. Epub 2011 May 15.

Effect of cholinergic stimulation in early Alzheimer's disease - functional imaging during a recognition memory task

Miettinen PS, Pihlajamäki M, Jauhiainen AM, Tarkka IM, Gröhn H, Niskanen E, Hänninen T, Vanninen R, Soininen H.

Curr Alzheimer Res. 2011 Nov;8(7):753-64. doi: 10.2174/156720511797633241.

[Efficacy of an occupational group therapy in degenerative dementias: a controlled study in the nursing home setting]

Pickel S, Grässel E, Luttenberger K.

Psychiatr Prax. 2011 Nov;38(8):389-96. doi: 10.1055/s-0030-1266137. Epub 2011 May 19.

Galantamine and behavior in Alzheimer disease: analysis of four trials

Kavanagh S, Gaudig M, Van Baelen B, Adami M, Delgado A, Guzman C, Jedenius E, Schäuble B.

Acta Neurol Scand. 2011 Nov;124(5):302-8. doi: 10.1111/j.1600-0404.2011.01525.x. Epub 2011 May 26.

Bionanotechnologies for treatment and diagnosis of Alzheimer's disease

Moghimi SM.

Nanomedicine. 2011 Oct;7(5):515-8. doi: 10.1016/j.nano.2011.05.001. Epub 2011 May 17.

Cognitive reserve and its implications for rehabilitation and Alzheimer's disease

Liberati G, Raffone A, Olivetti Belardinelli M.

Cogn Process. 2012 Feb;13(1):1-12. doi: 10.1007/s10339-011-0410-3. Epub 2011 Jun 4.

Cognitive improvement with intrathecal administration of infliximab in a woman with Alzheimer's disease

Shi JQ, Wang BR, Jiang WW, Chen J, Zhu YW, Zhong LL, Zhang YD, Xu J.

J Am Geriatr Soc. 2011 Jun;59(6):1142-4. doi: 10.1111/j.1532-5415.2011.03445.x.

Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer's dementia

Ahmed MA, Darwish ES, Khedr EM, El Serogy YM, Ali AM.

J Neurol. 2012 Jan;259(1):83-92. doi: 10.1007/s00415-011-6128-4. Epub 2011 Jun 14.

[Semantic memory training in Alzheimer's disease]

Goudour A, Samson S, Bakchine S, Ehrlé N.

Geriatr Psychol Neuropsychiatr Vieil. 2011 Jun;9(2):237-47. doi: 10.1684/pnv.2011.0272.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias